Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Bood POZ containing gene type 2 (BPOZ-2) is involved in the growth suppressive effect of the phosphatase and tensin homologue (PTEN). We showed that
BPOZ
-2 is a human counterpart of yeast Btb3p, which is a putative adaptor for Pcu3p-based ubiquitin ligase.
BPOZ
-2 bound to E3 ligase CUL3 in vitro and in vivo.
BPOZ
-2 itself was ubiquitinated through the CUL3-based E3 ligase mainly within the nucleus and degraded by the 26S
proteasome
. Although
BPOZ
-2 was mainly expressed within the cytoplasm, it accumulated within the nucleus in the presence of the specific 26S proteasome inhibitor MG132.
BPOZ
-2 may be recruited to the nucleus from the cytoplasm. Terminal deoxynucleotidyltransferase (TdT) was detected as a
BPOZ
-2-binding protein using a yeast two-hybrid system by screening a human thymus cDNA library. TdT,
BPOZ
-2, and CUL3 formed a ternary complex in vivo. TdT was ubiquitinated only within the nucleus and degraded by the 26S
proteasome
. The ubiqutination or degradation of TdT was markedly promoted by co-expression of
BPOZ
-2 and CUL3 or
BPOZ
-2 in 293T cells, respectively.
...
PMID:Bood POZ containing gene type 2 is a human counterpart of yeast Btb3p and promotes the degradation of terminal deoxynucleotidyltransferase. 1842 17
Bood POZ containing gene type 2 (BPOZ-2), which contains ankyrin repeats, NLS, BTB/POZ domains and LXXLL motifs, is an adaptor protein for the E3 ubiquitin ligase scaffold protein CUL3. We isolated a cDNA encoding eukaryotic elongation factor 1A1 (eEF1A1) as a
BPOZ
-2 binding protein by screening a human thymus cDNA library using a yeast two-hybrid system. eEF1A1 is essential for translation and is also involved in the 26S
proteasome
-dependent degradation of misfolded or unfolded proteins. The binding between
BPOZ
-2 and eEF1A1 was confirmed by pull-down and immunoprecipitation assays in vitro and in vivo, respectively.
BPOZ
-2 binds to eEF1A1 through the ankyrin repeats and both BTB/POZ domains in
BPOZ
-2 and Domains I and III in eEF1A1.
BPOZ
-2 and eEF1A1 over-expressed in HEK 293T cells co-localized as speckles within the cytoplasm.
BPOZ
-2 promoted eEF1A1 ubiquitylation and degradation, suggesting that eEF1A1 is a substrate of
BPOZ
-2.
BPOZ
-2 inhibited GTP binding to eEF1A1 and prevented translation in in vitro translation assay using rabbit reticulocytes.
...
PMID:BPOZ-2 directly binds to eEF1A1 to promote eEF1A1 ubiquitylation and degradation and prevent translation. 1845 63
Terminal deoxynucleotidyltransferase (TdT), which template-independently synthesizes DNA during V(D)J recombination in lymphoid cells, is ubiquitylated by a
BPOZ
-2/Cul3 complex, as the ubiquitin ligase, and then degraded by the 26 S
proteasome
. We show here that TdT is ubiquitylated by the Cul3-based ubiquitylation system in vitro. Because TdT could also be ubiquitylated in the absence of Cul/
BPOZ
-2, we determined that it could also be directly ubiquitylated by the E2 proteins UbcH5a/b/c and UbcH6, E3-independently. Furthermore, the ubiquitylated TdT inhibited its nucleotidyltransferase activity.
...
PMID:Ubiquitylation of terminal deoxynucleotidyltransferase inhibits its activity. 2280 41